Pelamed Pharmaceuticals had EBIT of $266 million in 2018, interest expenses of $71 million, and a corporate tax rate of 35%.

a. What was Pelamed's 2018 net income?

b. What was the total of Pelamed's 2018 net income and interest payments?

c. If Pelamed had no interest expenses, what would its 2018 net income have been? How does it compare to your answer in part a?

d. What was the amount of Pelamed's interest tax shield in 2018?